Making earlier cancer detection a routine part of medical care
EXACT SCIENCES
EXACT SCIENCES CORPORATION
Selected Unaudited Financial Information
Non-GAAP Gross Profit and Non-GAAP Gross Margin Reconciliations
(Amounts in thousands)
Revenue
Cost of sales (exclusive of amortization of acquired intangible assets)
Amortization of acquired intangible assets (1)
Gross profit
Gross margin
Amortization of acquired intangible assets (¹)
Non-GAAP gross profit
Non-GAAP gross margin
Three Months Ended September Nine Months Ended September
30,
30,
$
$
$
2022
523,073
147,937
21,296
353,840
68 %
21,296
375,136
72%
For associated footnote, please refer to the table in the third quarter 2022 results press release
labeled Non-GAAP Gross Profit and Non-GAAP Gross Margin Reconciliations
2021
$ 456,379
115,738
21,214
319,427
70%
$
$
2022
$ 1,531,284 $
427,242
66,250
$ 1,037,792
68%
21,214
340,641 $
75%
66,250
1,104,042
72%
$
2021
1,293,275
339,699
62,957
890,619
69 %
62,957
$ 953,576
74%
17View entire presentation